Log In
Print
BCIQ
Print
Print this Print this
 

Dulera, Zenhale (Mometasone/Formoterol) (MK-0887A)

Also known as: SCH 418131

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionFixed-dose combination of mometasone, an inhaled corticosteroid, and formoterol, a long-acting adrenergic receptor beta agonist (LABA)
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationAsthma
Indication DetailsMaintenance treatment of asthma in patients ages 12 and up
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today